Fielmann Group AG (FLMNF)
OTCMKTS · Delayed Price · Currency is USD
61.84
0.00 (0.00%)
Sep 10, 2025, 8:00 PM EDT
Fielmann Group AG Market Cap
Fielmann Group AG has a market cap or net worth of $5.44 billion as of September 12, 2025. Its market cap has increased by 32.14% in one year.
Market Cap
5.44B
Enterprise Value
5.87B
Revenue
2.82B
Ranking
n/a
PE Ratio
27.11
Stock Price
$61.84
Market Cap Chart
Since March 2, 1998, Fielmann Group AG's market cap has increased from 452.21M to 5.44B, an increase of 1,104.02%. That is a compound annual growth rate of 9.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 5.42B | 50.36% |
| Dec 30, 2024 | 3.61B | -20.12% |
| Dec 29, 2023 | 4.52B | 35.87% |
| Dec 30, 2022 | 3.32B | -40.90% |
| Dec 30, 2021 | 5.62B | -18.01% |
| Dec 30, 2020 | 6.86B | 1.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Elite Pharmaceuticals | 736.80M |
| Tian'an Technology Group | 732.84M |
| Glass House Brands | 585.86M |
| CytoDyn | 397.50M |
| Northwest Biotherapeutics | 380.94M |
| American Oncology Network | 346.29M |